Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine, discusses what makes a dermatology practice successful and the challenges that come with running a practice.
This content was produced independently by The American Journal of Managed Care® and is not endorsed by the American Academy of Dermatology.
Making sure your entire team is taken care of and that their work is enjoyable is part of ensuring a sustainable and successful practice, says Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine.
Transcript
What do you believe are some of the most important factors to consider to have a successful dermatology practice, and what are some of the biggest challenges?
It's a good question and an important one, of course, and I'll speak specifically through a pediatric lens since I work at a children's hospital and see just pediatric patients, but I think most of the lessons are generalizable. I think making sure that your entire team is well taken care of, first of all, because that's how you make sure that their work is enjoyable and therefore sustainable. And so, you can have continuity with your staff and your team, and that's gonna lead to better patient care.
You also want to, of course, make sure that you are listening to your patients and hearing the sorts of feedback that you get from them, whether it's family experience surveys, like our hospital gives, or any of those sort of mechanisms that allow you to hear what patients need.
There was a New York Times article a few years ago where a provider was building a new practice and actually decided to crowdsource information about his practice. And it wasn't a dermatology practice, but [it] basically asked his long-standing patients, "Hey, I'm developing a new office, what should I do to make this better for you?" And [he] was overwhelmed with 3000-plus responses, with things like gowns for all patient body types, not having doom scrolling TVs talking about bad news in the waiting room, letting patients maybe get dressed before you talk about things rather than having them persist in an uncomfortable state that all of us as providers and patients too, at times experience. So, just things like that. They seem like little things, but they can go a long way in terms of making practices more effective and sustainable.
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More